4 research outputs found
Effect of Iron Oxides (Ordinary and Nano) and Municipal Solid Waste Compost (MSWC) Coated Sulfur on Wheat (Triticum aestivum L.) Plant Iron Concentration and Growth
Abstract
A greenhouse study was conducted to compare the effects of ordinary iron oxide (0.02-0.06 mm) and nano iron oxide (25-250 nm) and five levels of both iron oxides (0, 0.05, 0.1, 0.5, and 1.0 %w/w) and two levels of sulfurous granular compost (MSW) (0 and 2% w/w) on plant height, spike length, grain weight per spike, total plant dry matter weight and thousands grain weight of wheat. The experimental factors were combined in factorial arrangement in a completely randomized design with 3 replications. Results showed that nano iron oxide was superior over ordinary iron oxide in all parameters studied. Fe concentration, spike length, plant height, grain weight per spike, total plant dry weight and thousands grain weight showed increasing trend per increase in both of iron oxides levels. Also, all parameters studied in sulfurous granular compost (MSW) treatment were superior over granular compost without sulfurous (MSW). This increase in all parameters were significantly higher when urban solid waste compost coated with sulfur coupled with nano iron oxide compared to urban sulfurous granular compost (MSW) along with ordinary iron oxide.
Keywords: Sulfurous granular compost (MSW), Nano and ordinary iron oxides, Whea
Impact of commissural calcification on clinical outcome of percutaneous balloon mitral valvuloplasty; a retrospective cohort study of 876 patients
Abstract Background Percutaneous balloon mitral valvuloplasty (PBMV) is the ACC/AHA class I recommendation for treating symptomatic rheumatic mitral stenosis with suitable valve morphology, less than moderate MR and absence of left atrium clot. The mitral valve restenosis and significant mitral regurgitation (MR) are known adverse outcomes of PBMV. This study aimed to evaluate the outcomes of PBMV in patients with severe mitral stenosis and the effect of Commissural Calcification (CC) on the outcomes. Methods In this single-center retrospective cohort study, 876 patients who underwent PBMV were categorized into three groups based on their Wilkins score (Group I: scoreββ€β8, Group II: score 9β10, and Group III: score 11β12). Patients were evaluated before, early after PBMV and at 6- and 24-month follow-ups. Main clinical outcomes were defined as significant restenosis and or symptomatic significant MR (moderate to severe and severe MR) or candidate for mitral valve replacement (MVR). The outcomes were compared between patients with and without CC. Results A total of 876 patients with mean age 46.4βΒ±β12.3 years (81.0% females) were categorized based on Wilkins score. 333 (38.0%) were in Group I, 501 (57.2%) were in Group II, and 42 (4.8%) were in Group III. CC was present in 175 (20.0%) of the patients, among whom 95 (54.3%) had calcification of the anterolateral commissure, 64 (36.6%) had calcification of the posteromedial commissure, and in 16 (9.1%) patients both commissures were calcified. There was a significant difference in Wilkins score between patients with and without CC (Pβ<β0.001). CC was associated with higher odds of significant symptomatic MR at early and mid-term follow up (OR: 1.69, 95%CI 1.19β2.41, Pβ=β0.003; and OR: 3.90, 95%CI 2.61β5.83, Pβ<β0.001, respectively), but not with restenosis (Pβ=β0.128). Wilkins Groups II and III did not show higher odds of significant symptomatic MR compared to Group I at early (II: Pβ=β0.784; III: Pβ=β0.098) and mid-term follow up (II: Pβ=β0.216; III: Pβ=β0.227). Patients in Wilkins Group II had higher odds of restenosis compared to Group I (OR: 2.96,95%CI: 1.35β6.27, Pβ=β0.007). Conclusion Commissural calcification (CC) is an independent predictor of the significant symptomatic MR (an important determinant of adverse outcome) following PBMV in the early and mid-term follow-up. Mitral valve restenosis occurs more in patients with higher Wilkins score compared to group I with scoreββ€β8. Combined Wilkins score and CC should be considered for patient suitability for PBMV